<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK548737" /><meta name="ncbi_domain" content="livertox" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK548737/" /><meta name="ncbi_pagename" content="Sevoflurane - LiverTox - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Sevoflurane - LiverTox - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]" /><meta name="citation_title" content="Sevoflurane" /><meta name="citation_publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="citation_date" content="2018/01/01" /><meta name="citation_pmid" content="31644046" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK548737/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Sevoflurane" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Institute of Diabetes and Digestive and Kidney Diseases" /><meta name="DC.Date" content="2018/01/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK548737/" /><meta name="description" content="Sevofurane is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia and has an excellent safety record. Sevoflurane has been implicated in rare single case reports of severe acute liver injury similar to halothane hepatitis." /><meta name="og:title" content="Sevoflurane" /><meta name="og:type" content="book" /><meta name="og:description" content="Sevofurane is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia and has an excellent safety record. Sevoflurane has been implicated in rare single case reports of severe acute liver injury similar to halothane hepatitis." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK548737/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/livertox/Sevoflurane/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK548737/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8D398E0467842100000000061401D4.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All Drug Records" href="/books/n/livertox/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-livertox-lrg.png" alt="Cover of LiverTox" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK548737_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK548737_dtls__"><div>Bethesda (MD): <a href="https://www.niddk.nih.gov/" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">National Institute of Diabetes and Digestive and Kidney Diseases</a>; 2012-.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/livertox/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Sertraline/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/ShoSaikoTo/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK548737_"><span class="title" itemprop="name">Sevoflurane</span></h1><p class="small">Last Update: <span itemprop="dateModified">January 1, 2018</span>.</p></div><div class="body-content whole_rhythm" itemprop="text"><div id="Sevoflurane.OVERVIEW"><h2 id="_Sevoflurane_OVERVIEW_">OVERVIEW</h2><div id="Sevoflurane.Introduction"><h3>Introduction</h3><p>Sevofurane is one of the most commonly used volatile anesthetic agents, particularly for outpatient anesthesia and has an excellent safety record. Sevoflurane has been implicated in rare single case reports of severe acute liver injury similar to halothane hepatitis.</p></div><div id="Sevoflurane.Background"><h3>Background</h3><p>Sevoflurane (see' voe flur' ane) is a widely used major anesthetic agent with rapid onset of action and rapid dispersal. Because of its rapid onset of action and lack of irritability to the airways, sevoflurane can be used to both induce and maintain anesthesia. Sevoflurane became available for use in the United States in 1995. Sevoflurane must be administered in a controlled situation by a properly trained and credentialed anesthesiologist or nurse anesthetist and is typically given in concentrations of 2% to 4% with oxygen.</p></div><div id="Sevoflurane.Hepatotoxicity"><h3>Hepatotoxicity</h3><p>Prospective, serial blood testing often demonstrates minor transient elevations in serum aminotransferase levels in the 1 to 2 weeks after major surgery. Appearance of <a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> levels above 10 times the upper limit of normal, however, is distinctly unusual and points to significant hepatotoxicity. Clinically apparent, severe hepatic injury from sevoflurane is very rare, only isolated case reports having been published. The injury is marked by acute elevations in serum aminotransferase levels (5- to 50-fold) and appearance of jaundice within 2 to 21 days of surgery. There are usually minimal increases in alkaline phosphatase and gammaglutamyl transpeptidase levels. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.jaundice/">Jaundice</a> is usually preceded by a day or two of fever and may be accompanied by rash and eosinophilia. The acute liver injury may be self-limited and resolve within 4 to 8 weeks, but can be severe and associated with acute liver failure. A strong risk factor is previous exposure to any of the halogenated anesthetics and particularly a history of halothane hepatitis or unexplained fever and rash after anesthesia with one of these agents. The differential diagnosis of acute liver injury after surgery and anesthesia is sometimes difficult, and a clinical picture similar to sevoflurane induced hepatitis can be caused by shock or ischemia, sepsis, other idiosyncratic forms of drug induced liver injury and acute viral or herpes hepatitis.</p><p>Likelihood score: B (highly likely cause of clinically apparent liver injury).</p></div><div id="Sevoflurane.Mechanism_of_Injury"><h3>Mechanism of Injury</h3><p>The mechanism of sevoflurane hepatotoxicity is suspected to be similar to that of halothane and associated with creation of reactive intermediates. Sevoflurane is metabolized to a small extent by the microsomal drug metabolizing enzyme CYP 2E1 to a trifluoroacetylated reactive intermediate (TFA) that is capable of binding to multiple intracytoplasmic proteins forming potentially immunogenic adducts. The TFA adducts induce antibodies that can be detected in patients with sevoflurane- as well as halothane hepatotoxicity and are also found in a proportion of health care workers exposed to the volatile anesthetics.</p></div><div id="Sevoflurane.Outcome_and_Management"><h3>Outcome and Management</h3><p>Severity ranges from mild and transient aminotransferase elevations without symptoms or other evidence of liver injury, to a self limited symptomatic acute hepatitis-like reaction to a severe, acute hepatic failure. The severity and prognosis may relate in part of patient age, being more severe in the elderly and both milder and less common in children. Obesity may also be both a predisposing factor and predictor of outcome. Chronic liver injury from sevoflurane exposure has not been described. Patients with sevoflurane induced hepatitis should be cautioned against future exposure to a fluorinated hydrocarbon anesthetic such as halothane, enflurane, isoflurane or desflurane.</p><p>Drug Class: <a href="/books/n/livertox/HalogenatedAnestheti/">Halogenated Anesthetics</a></p><p>Other Drugs in the Class: <a href="/books/n/livertox/Desflurane/">Desflurane</a>, <a href="/books/n/livertox/Enflurane/">Enflurane</a>, <a href="/books/n/livertox/Halothane/">Halothane</a>, <a href="/books/n/livertox/Isoflurane/">Isoflurane</a></p></div></div><div id="Sevoflurane.CASE_REPORTS"><h2 id="_Sevoflurane_CASE_REPORTS_">CASE REPORTS</h2><div id="Sevoflurane.Case_1._Suspected_sevofluran"><h3>Case 1. Suspected sevoflurane induced acute liver injury.</h3><p>[Modified from a case in the database of the Drug-Induced Liver Injury Network]</p><p>A 49 year woman underwent arthroscopic surgery on her knee using midazolam, fentanyl, propofol and sevoflurane. She received a single IV infusion of cefazolin at the time of surgery. Eighteen days after surgery, she developed nausea, heartburn, and pruritus followed by dark urine. She had undergone general anesthesia three times in the past, but not in the previous year and the anesthetics used were not known. On admission, she was afebrile and physical examination revealed jaundice and mild hepatic tenderness. Laboratory tests showed elevations in serum enzymes and a total bilirubin of 4.0 mg/dL. There was no eosinophilia. Tests for hepatitis A, B and C and autoantibodies were normal. A liver ultrasound showed a gall bladder polyp, but no evidence of biliary obstruction. A liver biopsy showed cholestatic hepatitis with mild bile duct injury. She recovered rapidly and was asymptomatic and had normal liver tests a few weeks later.</p><div id="Sevoflurane.Key_Points1"><h4>Key Points</h4><div id="Sevoflurane.T1" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548737/table/Sevoflurane.T1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Sevoflurane.T1_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Sevoflurane, 60 minutes anesthesia time</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular (R=5.4)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3+ (hospitalization for jaundice)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">18 days to symptoms</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3 weeks</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Anesthesia included fentanyl, propofol and versed. One dose of cefazolin given at the time of surgery. Postoperatively given ibuprofen, naproxen, hydrocodone, and occasional acetaminophen. Chronic therapy of allergies with Allegra and Nasonex.</td></tr></tbody></table></div></div></div><div id="Sevoflurane.Laboratory_Values1"><h4>Laboratory Values</h4><div id="Sevoflurane.T2" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548737/table/Sevoflurane.T2/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Sevoflurane.T2_lrgtbl__"><table><thead><tr><th id="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Postoperative Days</th><th id="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a><br /> (U/L)</th><th id="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Alk P<br /> (U/L)</th><th id="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">0</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2 hd_h_Sevoflurane.T2_1_1_1_3 hd_h_Sevoflurane.T2_1_1_1_4 hd_h_Sevoflurane.T2_1_1_1_5" colspan="4" rowspan="1" style="vertical-align:top;">Arthroscopic surgery under sevoflurane anesthesia</td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">24</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">618</td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">328</td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">4.0</td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">25</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">630</td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">373</td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">5.1</td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Liver biopsy</td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">28</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">543</td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">406</td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">5.0</td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">34</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">267</td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">285</td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">1.3</td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">39</td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">119</td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">181</td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">0.7</td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T2_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Sevoflurane.T2_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;45</b></td><td headers="hd_h_Sevoflurane.T2_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;130</b></td><td headers="hd_h_Sevoflurane.T2_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"></td><td headers="hd_h_Sevoflurane.T2_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Sevoflurane.Comment1"><h4>Comment</h4><p>This patient developed jaundice and hepatic injury within 3 weeks of surgery under sevoflurane anesthesia. While the liver injury was attributed to the anesthetic by the reviewing physicians, the pattern of onset (latency of 3 weeks), clinical features (absence of fever, early appearance of pruritus) and liver histology (cholestasis) were atypical of anesthetic induced hepatotoxicity and more characteristic of penicillin or cephalosporin induced liver disease. The liver biopsy suggested a cholestatic hepatitis, even though the initial liver enzyme elevations were &#x0201c;hepatocellular&#x0201d;. Indeed, this case was later re-adjudicated as being very likely due to cefazolin rather than sevoflurane.</p></div></div><div id="Sevoflurane.Case_2._Sevoflurane_induced_"><h3>Case 2. Sevoflurane induced acute liver injury.</h3><p>[Modified from: Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010; 17: 219-22. <a href="https://www.ncbi.nlm.nih.gov/pubmed/19455019" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a>]</p><p>A 37 year man underwent resection of an abdominal wall mass under midazolam, nitrous oxide, propofol and sevoflurane anesthesia and was discharged the same day. Three days after surgery, he developed nausea, vomiting, abdominal pain and jaundice. He had no history of liver disease, drug reactions, alcohol abuse or risk factors for viral hepatitis. He had undergone an appendectomy under general anesthesia four years previously, but the anesthetics used were not known. Other medications included postoperative pain management with codeine and acetaminophen (&#x0003c;1 gram daily). On admission, laboratory tests showed mild jaundice (total bilirubin 4.2 mg/dL, direct 1.8 mg/dL), but marked elevations in serum aminotransferase levels (<a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> 3364 U/L, <a class="def" href="/books/n/livertox/glossary/def-item/glossary.aspartate-aminotransferase-ast-/">AST</a> 3013 U/L) and minimal increase in alkaline phosphatase (336 U/L) and mild eosinophilia. These values had been mildly elevated one week previously at the time of a preoperative evaluation (Table). Tests for hepatitis A and B and autoantibodies were normal. Tests for Ebstein Barr virus suggested recent infection. A liver ultrasound showed no gallstones or evidence of biliary obstruction. During the first few days after admission he worsened with deepening jaundice and coagulopathy, the INR rising to 4.8. A liver biopsy showed centrolobular necrosis and inflammation and cholestasis with minimal or no fibrosis, suggestive of acute drug induced liver injury. <a class="def" href="/books/n/livertox/glossary/def-item/glossary.liver-transplantation/">Liver transplantation</a> was considered, but he then began to improve spontaneously and over the next 4 months his symptoms resolved and liver test results returned to normal.</p><div id="Sevoflurane.Key_Points2"><h4>Key Points</h4><div id="Sevoflurane.T3" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548737/table/Sevoflurane.T3/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Sevoflurane.T3_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Medication:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Sevoflurane anesthesia</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Pattern:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Hepatocellular (R=20)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Severity:</td><td rowspan="1" colspan="1" style="vertical-align:top;">4+ (hospitalization, jaundice and coagulopathy)</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.latency/">Latency</a>:</td><td rowspan="1" colspan="1" style="vertical-align:top;">3 days to symptoms</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Recovery:</td><td rowspan="1" colspan="1" style="vertical-align:top;">4 months</td></tr><tr><td rowspan="1" colspan="1" style="vertical-align:top;">Other medications:</td><td rowspan="1" colspan="1" style="vertical-align:top;">Anesthesia included nitrous oxide, propofol and midazolam. Postoperatively given acetaminophen (&#x0003c;1 gram daily) and codeine for pain</td></tr></tbody></table></div></div></div><div id="Sevoflurane.Laboratory_Values2"><h4>Laboratory Values</h4><div id="Sevoflurane.T4" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548737/table/Sevoflurane.T4/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Sevoflurane.T4_lrgtbl__"><table><thead><tr><th id="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Postoperative Days</th><th id="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.alanine-aminotransferase-alt-/">ALT</a> (U/L)</th><th id="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Alk P (U/L)</th><th id="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a class="def" href="/books/n/livertox/glossary/def-item/glossary.bilirubin/">Bilirubin</a> (mg/dL)</th><th id="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Other</th></tr></thead><tbody><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Pre</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">199</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">188</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">0.8</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">3</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">3064</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">336</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">4.2</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Admission</td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">6</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">4861</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">308</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">9.3</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">8</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">4137</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">292</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">12.7</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">10</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">1456</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">212</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">16.5</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">13</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">619</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">200</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">25.6</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">Liver biopsy</td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">18</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">130</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">208</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">30.4</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">21</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">120</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">214</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">31.2</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">60</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">43</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">364</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">16.1</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">105</td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">39</td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">140</td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">1.3</td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr><tr><td headers="hd_h_Sevoflurane.T4_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><b>Normal Values</b></td><td headers="hd_h_Sevoflurane.T4_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;60</b></td><td headers="hd_h_Sevoflurane.T4_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;121</b></td><td headers="hd_h_Sevoflurane.T4_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><b>&#x0003c;1.2</b></td><td headers="hd_h_Sevoflurane.T4_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div></div></div><div id="Sevoflurane.Comment2"><h4>Comment</h4><p>This patient developed jaundice and severe hepatic injury within 3 days of surgery under sevoflurane anesthesia. The clinical course was typical of halogenated anesthetic liver injury with a rapid onset, mild eosinophilia, a hepatocellular pattern of injury and severe course. Risk factors included previous anesthesia (although the agent used was not known). Unexplained were the abnormal liver tests obtained before surgery and the equivocal serology of EBV infection. Results of tests for hepatitis C and E were not provided.</p></div></div></div><div id="Sevoflurane.PRODUCT_INFORMATION_Halogena"><h2 id="_Sevoflurane_PRODUCT_INFORMATION_Halogena_">PRODUCT INFORMATION</h2><div id="Sevoflurane.BPI" class="box"><p><b>REPRESENTATIVE TRADE NAMES</b></p><p>Sevoflurane &#x02013; Generic, Sevorane&#x000ae;, Ultane&#x000ae;</p><p><b>DRUG CLASS</b></p><p>Anesthetics, Halogenated</p><p><a href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=halogenated+anesthetics" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">COMPLETE LABELING</a></p><p>Product labeling at DailyMed, National Library of Medicine, NIH</p></div></div><div id="Sevoflurane.CHEMICAL_FORMULA_AND_STRUCTU"><h2 id="_Sevoflurane_CHEMICAL_FORMULA_AND_STRUCTU_">CHEMICAL FORMULA AND STRUCTURE</h2><div id="Sevoflurane.T5" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK548737/table/Sevoflurane.T5/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__Sevoflurane.T5_lrgtbl__"><table><thead><tr><th id="hd_h_Sevoflurane.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">DRUG</th><th id="hd_h_Sevoflurane.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">CAS REGISTRY NO</th><th id="hd_h_Sevoflurane.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">MOLECULAR FORMULA</th><th id="hd_h_Sevoflurane.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">STRUCTURE</th></tr></thead><tbody><tr><td headers="hd_h_Sevoflurane.T5_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Sevoflurane</td><td headers="hd_h_Sevoflurane.T5_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://pubchem.ncbi.nlm.nih.gov/substance/134997737" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubchem">28523-86-6</a></td><td headers="hd_h_Sevoflurane.T5_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">C4-H3-F7-O</td><td headers="hd_h_Sevoflurane.T5_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><div class="graphic"><img src="/books/NBK548737/bin/Sevoflurane_Structure.jpg" alt="Sevoflurane chemical structure" /></div></td></tr></tbody></table></div></div></div><div id="Sevoflurane.ANNOTATED_BIBLIOGRAPHY"><h2 id="_Sevoflurane_ANNOTATED_BIBLIOGRAPHY_">ANNOTATED BIBLIOGRAPHY</h2><p>References updated: 01 January 2018</p><ul class="first-line-outdent"><li><div class="bk_ref" id="Sevoflurane.R1">Zimmerman HJ. Anesthetic agents. In, Zimmerman, HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999: pp. 457-82.<div><i>(Expert review of hepatotoxicity of anesthetic agents published in 1999; mentions that the newer halogenated anesthetics appear to be safer than halothane, but that hints of liver injury from desflurane and sevoflurane have appeared).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R2">Kenna JG. Mechanism, pathology, and clinical presentation of hepatoxicity of anesthetic agents. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 3rd ed. Amsterdam: Elsevier, 2013: pp 403-22.<div><i>(Review of liver injury from anesthetic agents mentions that several cases of sevoflurane hepatotoxicity were reported from Japan, where it was used widely at least 10 years before introduction into the United States, and several cases have subsequently been reported from other countries). </i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R3">Patel PM, Patel HH, Roth DM. General anesthetics and therapeutic gases. In, Brunton LL, Chabner BA, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill, 2011, pp. 527-64.<div><i>(Textbook of pharmacology and therapeutics).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R4">Ogawa M, Doi K, Mitsufuji T, Satoh K, Takatori T. [Drug induced hepatitis following sevoflurane anesthesia in a child] Masui 1991; 40: 1542-5. Japanese.  [<a href="/pubmed/1766104" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1766104</span></a>]<div><i>(11 year old boy with first exposure to sevoflurane developed 15-20 fold elevations in ALT and AST without jaundice 11-22 days after anesthesia).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R5">Shichinohe Y, Masuda Y, Takahashi H, Kotaki M, Omote T, Shichinohe M, Namiki A. [A case of postoperative hepatic injury after sevoflurane anesthesia] Masui 1992; 41: 1802-5. Japanese.  [<a href="/pubmed/1460759" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1460759</span></a>]<div><i>(63 year old man underwent surgery under sevoflurane anesthesia and had ALT elevations starting on postoperative day 3 and jaundice on day 7 [peak bilirubin 14.5 mg/dL, ALT 700 U/L], resolving within 2 months).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R6">Watanabe K, Hatakenaka S, Ikemune K, Chigyo Y, Kubozono T, Arai T. [A case of suspected liver dysfunction induced by sevoflurane anesthesia] Masui 1993; 42: 902-5. Japanese.  [<a href="/pubmed/8320810" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8320810</span></a>]<div><i>(One month old male infant developed fever followed by 5-8 fold elevations in ALT [326 KU/L], AST [242 KU/L] and LDH [901 WU/L], without jaundice after sevoflurane anesthesia).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R7">Ohmori H, Seki S, Kanaya N, et al. A case report of postoperative liver dysfunction following sevoflurane anesthesia after isoflurane anesthesia. J Jpn Soc Clin Anesth 1994; 14: 68-71.<div><i>Not in PubMed.</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R8">Fee JP, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf 1997; 16: 157-70.  [<a href="/pubmed/9098654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9098654</span></a>]<div><i>(Review of metabolism and literature on hepatotoxicity of halogenatic anesthetics: halothane is extensively metabolized [oxidized] by the liver and major metabolite is TFA which may be a toxic intermediary metabolite).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R9">Nishiyama T, Yokoyama T, Hanaoka K. Liver function after sevoflurane or isoflurane anaesthesia in neurosurgical patients. Can J Anaesth 1998; 45: 753-6.  [<a href="/pubmed/9793665" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9793665</span></a>]<div><i>(Prospective analysis of ALT, AST, Alk P and bilirubin levels after sevoflurane or isoflurane [n=45 each] showed minimal increases in ALT and AST peaking at 7 days; elevated in ~20% of patients, but none were symptomatic or jaundiced).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R10">Bruun LS, Elkjaer S, Bitsch-Larsen D, Andersen O. Hepatic failure in a child after acetaminophen and sevoflurane exposure. Anesth Analg 2001; 92: 1446-8.  [<a href="/pubmed/11375824" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11375824</span></a>]<div><i>(3 year old girl developed marked ALT [&#x0003e;10,000 U/L], AST [&#x0003e;7000 U/L] and LDH [37,923 U/L] elevations by day 4 after appendectomy under sevoflurane anesthesia, with jaundice [3.5 mg/dL], coma and coagulopathy, ultimately resolving; exposed to many other drugs including rectal acetaminophen).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R11">Siddiqui MS, Vollers JM, Mayhew JF. Did sevoflurane contribute to hepatic failure in a child given large doses of acetaminophen? Anesth Analg 2002; 95: 253;  [<a href="/pubmed/12088983" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12088983</span></a>]<div><i>(Letter arguing that case described by Bruun [2001] was due to acetaminophen).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R12">Reich A, Everding AS, Bulla M, Brinkmann OA, Van Aken H. Hepatitis after sevoflurane exposure in an infant suffering from primary hyperoxaluria type 1. Anesth Analg 2004; 99: 370-2, table of contents.  [<a href="/pubmed/15271707" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15271707</span></a>]<div><i>(11 month of infant developed marked ALT [543 U/L], AST [683 U/L] and LDH [960 U/L] elevations 2 days after sevoflurane anesthesia, which returned to baseline within days without jaundice, fever, or eosinophilia, possibly due to ischemic hepatitis).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R13">Russo MW, Galanko JA, Shrestha R, Fried MW, Watkins P. Liver transplantation for acute liver failure from drug-induced liver injury in the United States. Liver Transpl 2004; 10: 1018-23.  [<a href="/pubmed/15390328" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15390328</span></a>]<div><i>(Among ~50,000 liver transplants done in the United States between 1990 and 2002, 137 [0.2%] were done for idiosyncratic drug induced acute liver failure, of which 3 were attributed to halothane and 1 to isoflurane, but none to other halogenated anesthetics).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R14">Jang Y, Kim I. Severe hepatotoxicity after sevoflurane anesthesia in a child with mild renal dysfunction. Paediatr Anaesth 2005; 15: 1140-4.  [<a href="/pubmed/16324041" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16324041</span></a>]<div><i>(6 year old girl had rise of ALT [peak 744 U/L] and AST [peak 2125 U/L] levels 2-7 days after renal biopsy and sevoflurane anesthesia, with fever and malaise but no jaundice; no previous exposures).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R15">Bj&#x000f6;rnsson E, Jerlstad P, Bergqvist A, Olsson R. Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 2005; 40: 1095-101.  [<a href="/pubmed/16165719" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16165719</span></a>]<div><i>(36 years of reporting to Swedish registry identified 103 cases of acute liver failure due to drugs, of which 16 were attributed to halothane [ranking #1], but none to other halogenated anesthetics).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R16">Bj&#x000f6;rnsson E, Olsson R. Suspected drug-induced liver fatalities reported to the WHO database. Dig Liver Dis 2006; 38: 33-8.  [<a href="/pubmed/16054882" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16054882</span></a>]<div><i>(In WHO database of fatal adverse drug reactions from 1968-2003, there were 4690 reports of drug induced liver fatalities; halothane ranked fifth in frequency but most cases were reported before 1991).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R17">Lehmann A, Neher M, Kiessling AH, Isgro F, Koloska A, Boldt J. Case report: fatal hepatic failure after aortic valve replacement and sevoflurane exposure. Can J Anaesth 2007; 54: 917-21.  [<a href="/pubmed/17975238" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17975238</span></a>]<div><i>(76 year old woman developed acute liver failure within days of sevoflurane anesthesia for cardiac surgery [bilirubin 1.0 rising to 2.7 mg/dL, ALT 10504 U/L, Alk P 125 U/L, LDH 12,944 U/L]; course more typical of ischemic than anesthetic hepatitis).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R18">Turillazzi E, D'Errico S, Neri M, Riezzo I, Fineschi V. A fatal case of fulminant hepatic necrosis following sevoflurane anesthesia. Toxicol Pathol 2007; 35: 840-5.  [<a href="/pubmed/17943651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17943651</span></a>]<div><i>(69 year old man developed marked rises in ALT [641 U/L], AST [2196 U/L] and LDH 20 hours after initial surgery under sevoflurane anesthesia, with further rises &#x0003e;1000 U/L after emergency surgery and reexposure to sevoflurane, with death 8 days later).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R19">Alotaibi WM. Severe hepatic dysfunction after sevoflurane exposure. Saudi Med J 2008; 29: 1344-6.  [<a href="/pubmed/18813426" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18813426</span></a>]<div><i> (6 year old underwent craniotomy under sevoflurane anesthesia developed high ALT levels [2891 U/L] immediately postoperatively, which fell to normal by day 7 at which time she developed thrombocytopenia, intracerebral bleeding and coma resulting in death by day 9).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R20">Fern&#x000e1;ndez-Mer&#x000e9; LA, Mu&#x000f1;oz Gonz&#x000e1;lez F, Sopena Zubiria LA, Alvarez Blanco M. [Sevoflurane and liver dysfunction]. Rev Esp Anestesiol Reanim 2008; 55 :184-5. Spanish.  [<a href="/pubmed/18401994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18401994</span></a>]<div><i>(61 year old woman developed fatigue, fever and elevations in ALT [334 and 109 U/L and GGT 121 and 194 U/L] 2 to 4 weeks after sevoflurane anesthesia on two occasions without jaundice and with full resolution in 2 weeks).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R21">Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J, Yang H, Rochon J; Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology 2008; 135: 1924-34.  [<a href="/pmc/articles/PMC3654244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3654244</span></a>] [<a href="/pubmed/18955056" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18955056</span></a>]<div><i> (Among 300 cases of drug induced liver disease collected in the US between 2003 and 2008, 2 cases were attributed to desflurane and 1 to sevoflurane [see Case 1], none to other halogenated anesthetics).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R22">Zizek D, Ribnikar M, Zizek B, Ferlan-Marolt V. Fatal subacute liver failure after repeated administration of sevoflurane anaesthesia. Eur J Gastroenterol Hepatol 2010; 22: 112-5. ( [<a href="/pubmed/19657276" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19657276</span></a>]<div><i>66 year old woman exposed to sevoflurane anesthesia twice in 25 days developed jaundice and subacute liver failure arising 2 weeks later [bilirubin 31.5 mg/dL, ALT 2400 U/L, Alk P 282 U/L, INR 2.0], progressing to hepatic failure and death 66 days after second anesthesia; autopsy showed massive necrosis).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R23">Singhal S, Gray T, Guzman G, Verma A, Anand K. Sevoflurane hepatotoxicity: a case report of sevoflurane hepatic necrosis and review of the literature. Am J Ther 2010; 17: 219-22.  [<a href="/pubmed/19455019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19455019</span></a>]<div><i>(37 year old man developed nausea and jaundice 3 days after sevoflurane anesthesia [bilirubin 4.2 rising to 30.4 mg/dL; ALT 3364 U/L, Alk P 336 U/L], resolving within 3 months).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R24"><div><i>Devarbhavi H, Dierkhising R, Kremers WK, Sandeep MS, Karanth D, Adarsh CK. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality. Am J Gastroenterol 2010; 105: 2396-404. <a href="https://www.ncbi.nlm.nih.gov/pubmed/20648003" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a> (313 cases of drug induced liver injury were seen over a 12 year period at a large hospital in Bangalore, India; none were attributed to anesthetic agents).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R25">Reuben A, Koch DG, Lee WM; Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. Multicenter, prospective study. Hepatology 2010; 52: 2065-76.  [<a href="/pmc/articles/PMC3992250/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3992250</span></a>] [<a href="/pubmed/20949552" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20949552</span></a>]<div><i>(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury inlcuding one due to halothane and one to isoflurane, but none to other anesthetic agents).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R26"><div><i>Ferrajolo C, Capuano A, Verhamme KM, Schuemie M, Rossi F, Stricker BH, Sturkenboom MC. Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase. Br J Clin Pharmacol 2010; 70: 721-8. <a href="https://www.ncbi.nlm.nih.gov/pubmed/21039766" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">PubMed Citation</a> (Worldwide pharmacovigilance database contained 9036 hepatic adverse drug reactions in children, no anesthetic agent ranked in the top 41 causes).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R27">Nicoll A, Moore D, Njoku D, Hockey B. Repeated exposure to modern volatile anaesthetics may cause chronic hepatitis as well as acute liver injury. BMJ Case Rep 2012; 2012. (Description of 4 cases of chronic hepatitis in patients who had repeated surgical exposures to sevoflurane and were found to have antibodies to CYP 2E1 and TFA). [<a href="/pmc/articles/PMC3666850/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3666850</span></a>] [<a href="/pubmed/23131606" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23131606</span></a>]</div></li><li><div class="bk_ref" id="Sevoflurane.R28">Masin-Spasovska J, Dimitrovski K, Stavridis S, Stankov O, Dohcev S, Saidi S, Jakovski K, et al. Acute fulminant hepatatis in kidney transplant recipient after repeated sevoflurane anesthesia--a case report and literature review. Curr Drug Saf 2013; 8: 141-4.  [<a href="/pubmed/23845191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23845191</span></a>]<div><i> (47 year old woman developed renal failure and hypotension after renal transplantation and required reoperation 2 days later, which was followed by ALT [3,300 U/L] and LDH [8,900 U/L] elevations which the authors attributed to sevoflurane anesthesia, but may have been due to shock and ischemia).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R29">Nishiyama T. Effects of repeat exposure to inhalation anesthetics on liver and renal function. J Anaesthesiol Clin Pharmacol 2013; 29: 83-7.  [<a href="/pmc/articles/PMC3590549/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3590549</span></a>] [<a href="/pubmed/23493664" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23493664</span></a>]<div><i> (Retrospective analysis of 206 patients who underwent anaesthesia twice within a 1 year period found higher rates of ALT elevations within 16 days after isoflurane [60-83%] than sevoflurane [24-30%] or propofol-fentanyl [12-17%], most elevations being less than twice ULN and no differences between first and second exposures).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R30">Safari S, Motavaf M, Seyed Siamdoust SA, Alavian SM. Hepatotoxicity of halogenated inhalational anesthetics. Iran Red Crescent Med J 2014; 16: e20153.  [<a href="/pmc/articles/PMC4270648/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4270648</span></a>] [<a href="/pubmed/25593732" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25593732</span></a>]<div><i>(Review of hepatotoxicity of the volatile halogenated anesthetics).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R31">Lin J, Moore D, Hockey B, Di Lernia R, Gorelik A, Liew D, Nicoll A. Drug-induced hepatotoxicity: incidence of abnormal liver function tests consistent with volatile anaesthetic hepatitis in trauma patients. Liver Int 2014; 34: 576-82.  [<a href="/pubmed/23944929" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23944929</span></a>]<div><i> (Retrospective analysis of records from 1556 patients admitted to a trauma unit during 2008 identified 47 cases of possible volatile anesthetic related liver injury, including 12 who developed ALT levels above 200 U/L of whom 11 had fever and 6 eosinophilia, but none were jaundiced or developed acute liver failure).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R32">Hern&#x000e1;ndez N, Bessone F, S&#x000e1;nchez A, di Pace M, Brahm J, Zapata R, A Chirino R, et al. Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports. Ann Hepatol 2014; 13: 231-9. (Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases of which 5 [3%] were attributed to halothane and caused acute liver failure, while. [<a href="/pubmed/24552865" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24552865</span></a>]<div><i>no other volatile anesthetic was listed).</i></div></div></li><li><div class="bk_ref" id="Sevoflurane.R33">Chalasani N, Bonkovsky HL, Fontana R, Lee W, Stolz A, Talwalkar J, Reddy KR, et al.; United States Drug Induced Liver Injury Network. Features and outcomes of 899 patients with drug-induced liver injury: The DILIN Prospective Study. Gastroenterology 2015; 148: 1340-52.e7.  [<a href="/pmc/articles/PMC4446235/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4446235</span></a>] [<a href="/pubmed/25754159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25754159</span></a>]<div><i>(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 2 were attributed to isoflurane, 1 to sevoflurane, but none to halothane, enflurane or desflurane).</i></div></div></li></ul></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK548737</span><span class="label">PMID: <a href="/pubmed/31644046" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">31644046</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/livertox/">Drug Records</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/livertox/Sertraline/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/livertox/ShoSaikoTo/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK548737&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK548737/?report=reader">PubReader</a></li><li><a href="/books/NBK548737/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK548737" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK548737" style="display:none" title="Cite this Page"><div class="bk_tt">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-.  Sevoflurane. [Updated 2018 Jan 1].<span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK548737/pdf/Bookshelf_NBK548737.pdf">PDF version of this page</a> (135K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Bulk Download</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://ftp.ncbi.nlm.nih.gov/pub/litarch/29/31/" ref="pagearea=source-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Bulk download LiverTox data from FTP</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Overviews</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/intro/">Introduction</a></li><li><a href="/books/n/livertox/Causality/">Causality</a></li><li><a href="/books/n/livertox/ClinicalCourse/">Clinical Course</a></li><li><a href="/books/n/livertox/ClinicalOutcome/">Clinical Outcomes</a></li><li><a href="/books/n/livertox/ImmuneFeatures/">Immune Features</a></li><li><a href="/books/n/livertox/DrugCategory/">Likelihood Scale</a></li><li><a href="/books/n/livertox/Phenotypes_intro/">Phenotypes</a></li><li><a href="/books/n/livertox/Severity/">Severity Grading</a></li><li><a href="/books/n/livertox/CaseReport/">Writing a Case Report</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Support Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/livertox/">LiverTox Homepage</a></li><li><a href="/books/n/livertox/aboutus/">About LiverTox</a></li><li><a href="/books/n/livertox/editorsandreviewers/">Editors and Review Committee</a></li><li><a href="/books/n/livertox/alert/">Meetings and News</a></li><li><a href="/books/n/livertox/abbreviation/">Abbreviations Used</a></li><li><a href="/books/n/livertox/glossary/">Glossary</a></li><li><a href="/books/n/livertox/resource/">Information Resources</a></li><li><a href="/books/n/livertox/disclaimer/">User/Medical Advice Disclaimer</a></li><li><a href="/books/n/livertox/Contactus/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>OTHER REFERENCE LINKS</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&amp;db=pubmed&amp;pubmedfilters=true&amp;term=sevoflurane+AND+methyl+ethers/AE+AND+Human%5BMH%5D+AND+(jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI+OR+hepatitis,+toxic%5BMH%5D)+AND+(%222009/1/1%22%5BEDat%5D%3A%222999/12/31%22%5BEDat%5D)" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Recent References on Sevoflurane: from PubMed.gov</a></li><li><a href="https://clinicaltrials.gov/ct2/results?term=sevoflurane" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Trials on Sevoflurane: from ClinicalTrials.gov</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=4860894" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pcsubstance&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pcsubstance&amp;IdsFromResult=4860894" ref="log$=recordlinks">PubChem Substance</a><div class="brieflinkpop offscreen_noflow">Related PubChem Substances</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=4860894" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31644158" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Halogenated Anesthetics</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Halogenated Anesthetics<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31644026" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Desflurane</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Desflurane<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/7832332" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Clinical characteristics of sevoflurane in children. A comparison with halothane.</a><span class="source">[Anesthesiology. 1995]</span><div class="brieflinkpop offscreen_noflow">Clinical characteristics of sevoflurane in children. A comparison with halothane.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Sarner JB, Levine M, Davis PJ, Lerman J, Cook DR, Motoyama EK. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Anesthesiology. 1995 Jan; 82(1):38-46. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/8659783" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Preservation of the ration of cerebral blood flow/metabolic rate for oxygen during prolonged anesthesia with isoflurane, sevoflurane, and halothane in humans.</a><span class="source">[Anesthesiology. 1996]</span><div class="brieflinkpop offscreen_noflow">Preservation of the ration of cerebral blood flow/metabolic rate for oxygen during prolonged anesthesia with isoflurane, sevoflurane, and halothane in humans.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kuroda Y, Murakami M, Tsuruta J, Murakawa T, Sakabe T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Anesthesiology. 1996 Mar; 84(3):555-61. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31643972" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Anesthetics, General</a><span class="source">[LiverTox: Clinical and Researc...]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Anesthetics, General<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. 2012</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=31644046" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=31644046" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=6046931eddcb804c59367574">Sevoflurane - LiverTox</a><div class="ralinkpop offscreen_noflow">Sevoflurane - LiverTox<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2021-03-08T16:11:58-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@9.2&amp;Host=portal106&amp;ncbi_phid=CE8D398E0467842100000000061401D4&amp;ncbi_session=CE8D398E046931E1_1556SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK548737%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK548737&amp;ncbi_domain=livertox&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK548737/&amp;ncbi_pagename=Sevoflurane - LiverTox - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8D398E046931E1_1556SID /projects/books/PBooks@9.2 portal106 v4.1.r621975 Fri, Dec 18 2020 02:56:50 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4192745/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>